Editorial Board
57 Editors in 11 Countries/Regions
Editor-in-Chief
Godefridus J. Peters 
gj.peters@amsterdamumc.nl Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers (Amsterdam UMC), Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Department of Biochemistry, Medical University of Gdansk, Gdansk, Poland.
Research Interests: cancer biomarkers, apoptosis, lung diseases, cell culture, gene expression, pharmacokinetics, pharmacodynamics and pharmacogenetics of anticancer drugs, gastrointestinal cancers, translational research, animal models, drug metabolism and transport, influx and efflux proteins.
Protective autophagy by thymidine causes resistance to rapamycin in colorectal cancer cells in vitro
Resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer
How to overcome ATP-binding cassette drug efflux transporter-mediated drug resistance?
Co-Editor-in-Chief
Yehuda G. Assaraf
Department of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
Research Interests: molecular mechanisms of anticancer drug resistance, drug discovery, physiology.
Associate Editors
Wafik El-Deiry
Legorreta Cancer Center, Brown University, Providence, RI, USA.
Research Interests: autophagy, p53 tumor suppression, cell death signaling pathways, DNA damage, TRAIL pathway, hypoxia, drug resistance, novel therapeutics, translational oncology.
Liwu Fu
State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
Research Interests: ABC transporter, cancer therapy, chemotherapy resistance, multidrug resistance, immune checkpoint blockade, leukemia.
Elisa Giovannetti
Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers (Amsterdam UMC), Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Cancer Pharmacology Lab, Fondazione Pisana per la Scienza, Pisa, Italy.
Research Interests: molecular pharmacology, chemoresistance, pancreatic cancer, thoracic cancers.
Targeted therapies in cancer: where are we going?
Resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer
Paola Perego
Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Research Interests: molecular biology, p53, DNA damage, apoptosis, cytotoxicity, pharmacology, cancer cell line.
Chiara Riganti
Department of Oncology, University of Torino, Torino, Italy.
Research Interests: chemo-immunoresistant tumor models, lung cancer, prostate cancer, breast cancer, malignant pleural mesothelioma, glioblastoma multiforme, multiple myeloma.
Hailin Tang
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
Research Interests: cancer, metastasis, metabolism, animal model, non-coding RNA.
Editorial Board Members
Aamir Ahmad
Dermatology Institute and Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
Research Interests: non-coding RNAs expression, signaling in cancer metastasis, circulating and tissue biomarkers.
Suresh V. Ambudkar
Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Research Interests: ATP-binding cassette (ABC) drug transporters, drug resistance, membrane biochemistry, chemoresistance, transport proteins.
The multidrug resistance transporter P-glycoprotein confers resistance to ferroptosis inducers
Farrukh Aqil
Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY, United States.
Research Interests: exosomes, drug delivery, cancer, cancer chemoprevention, extra cellular vesicles
Maria R. Baer
University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
Research Interests: acute myeloid leukemia, FLT3 internal tandem duplication, signaling pathways, kinase inhibitors, drug resistance.
Stergios Boussios
Faculty of Life Sciences and Medicine, King's College London, London, UK.
Research Interests: cancer treatment, cancer in pregnancy, cancer diagnostics, cancer biology, cancer biomarkers, gynaecological cancers, urological cancers, colorectal cancer, autoimmunity.
Claudio Cerchione
Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
Research Interests: myelodysplastic syndromes, hematological malignancies, lymphoma, multiple myeloma, hematologic diseases, clinical hematology, blood disorders, acute myeloid leukemia, chemotherapy, leukemia, acute lymphoblastic leukemia.
Wei Chen
Department of Physics, The University of Texas at Arlington, Arlington, TX, USA.
Research Interests: nanomedicine, cancer nanotechnology, drug delivery, targeting, hypoxia, cancer resistance, radiotherapy, photodynamic therapy, photothermal therapy, chemodynamic therapy.
Zhesheng Chen
Department of Pharmaceutical Sciences, St. John’s University, Queens, NY, USA.
Research Interests: ABC transporters, multidrug resistance, cancer pharmacology.
Liang Cheng
Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School, Brown University Health, Providence, RI, USA.
Research Interests: pathology, biomarker, genitourinary malignancies, bladder cancer.
William C Cho
Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China.
Research Interests: cancer biomarkers, drug repurposing, non-coding RNA, proteomics.
Mario Cioce
Laboratory of Molecular Medicine and Biotechnology, University Campus Bio-Medico of Rome, Rome, Italy.
Research Interests: mesothelioma, metformin, CSC, translational oncology, chemoresistance, TKI, Ephrin, EMT.
Jacqueline Cloos
Department of Hematology, VU University Medical Center, Amsterdam, Netherlands.
Research Interests: proteasome inhibitors, minimal residual disease, clonal evolution, splicing, cellular drug addiction, hematology, drug combination studies.
Paul Dent
Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, VA, USA.
Research Interests: cancer therapeutics, rational combination of drugs, molecular mechanisms, drug combinations synergize, breast, brain, liver and pancreatic cancers.
Changming Dong
School of Chemistry & Chemical Engineering, Shanghai Jiao Tong University, Shanghai, China.
Research Interests: biodegradable polymer nanomedicine, cancer combination therapy, drug delivery systems, multidrug resistance.
Thomas Efferth
Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Mainz, Germany.
Research Interests: natural product chemistry, medicinal and pharmaceutical chemistry, virtual drug screening, transcriptomics, network pharmacology, biochemistry, drug development, apoptosis, cancer biology.
Marco Falasca
Curtin Health Innovation Research Institute, Curtin University, Perth, Australia.
Research Interests: pancreatic cancer, exosomes, lipid metabolism, membrane transporters, signal transduction, cancer invasion and metastasis, phosphoinositide signalling, cannabinoids.
David A. Gewirtz
Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA.
Research Interests: autophagy, senescence, cancer chemotherapy, chemosensitization, radiosensitization, chemtoxicity.
Jean-Pierre Gillet
Laboratory of Molecular Cancer Biology, Faculty of Medicine, University of Namur, Namur, Belgium.
Research Interests: ATP-binding cassette transporters, cancer multidrug resistance mechanisms, pharmacogenomics, cancer biology, transcriptomics.
William Gmeiner
Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Research Interests: colorectal cancer, fluoropyrimidine, thymidylate synthase, DNA topoisomerase, aberrant signaling pathways in tumor cells.
Targeting DNA topoisomerases: past & future
Improved potency of F10 relative to 5-fluorouracil in colorectal cancer cells with p53 mutations
Entrapment of DNA topoisomerase-DNA complexes by nucleotide/nucleoside analogs
Targeting DNA Topoisomerases: Past & Future
Review of 5-FU Resistance Mechanisms in Colorectal Cancer Attenuating On-Target Effects
Michael M Gottesman
Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Research Interests: cancer therapy, drug resistance, nanotechnology, theranostics, biomarker.
The multidrug resistance transporter P-glycoprotein confers resistance to ferroptosis inducers
Alessandro Granito
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Department of Medical and Surgical Sciences (DIMEC),University of Bologna, Italy.
Research Interests: hepatocellular carcinoma, primary liver cancer, intrahepatic cholangiocarcinoma, cancer immunology, liver immunology, cancer immunotherapy, tyrosine kinase inhibitors, transarterial chemoembolization, radioembolization.
Sanjay Gupta
Department of Urologic Oncology, Case Western Reserve University, Cleveland, OH, USA.
Research Interests: cancer chemoprevention, cancer therapeutics, drug resistance, drug repurposing, translational oncology, cancer biology, signal transduction, apoptosis, antioxidant activity, artificial intelligence, cancer biomarkers, diet nutrition and cancer, drug delivery, toxicology, epigenetics, inflammation, cancer stem cells.
Emerging targets in cancer drug resistance
Resistance to second generation antiandrogens in prostate cancer: Pathways and mechanisms
Prostate cancer stem cells and their role in antiandrogen resistance
New Insights for drug resistance in metastatic castration-resistant prostate cancer
Dominique Heymann
Institut de Cancérologie de l'Ouest, Tumour Heterogeneity and Precison Medicine Laboratory, Saint-Herblain, France.
Research Interests: circulating tumour cells, pathogenesis of bone sarcoma, osteoclast differentiation, metastatic process.
Yi Huang
Department of Internal Medicine, Division of Hematology, Oncology and Blood & Marrow Transplantation, University of Iowa Carver College of Medicine, Iowa City, IA, USA.
Research Interests: breast cancer, epigenetics, multidrug resistance, cancer pharmacology, immuno-oncology, drug combination, precision medicine
Zhiqing Huang
Department of Obstetrics and Gynecology, Division of Reproductive Sciences, Duke University Medical Center, Durham, NC, USA.
Research Interests: ovarian cancer, cancer chemoresistance, tumor microenvironment, epigenetics and epigenomics.
Thomas E. Hutson
Hematology and Medical Oncology, UC Davis Health, Sacramento, CA, USA;
UMC Cancer Center, Lubbock, TX, USA; Texas Tech University Health Science Center, Lubbock, TX, USA.
Research Interests: renal cell carcinoma, bladder cancer, prostate cancer, testicular cancer, immunotherapy.
Gerrit Jansen
Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, Location VUmc, Amsterdam, the Netherlands.
Research Interests: rheumatology, cancer biology and immunology, imaging and biomarkers, inflammatory diseases, antifolates, proteasome inhibitors, (multi) drug resistance.
Dexin Kong
School of Pharmaceutical Sciences, Tianjin Medical University, Tianjin, China.
Research Interests: molecular targeted drug, natural products, cancer chemotherapy, traditional Chinese medicine in anti-tumor treatment.
Hang Fai Kwok
Faculty of Health Sciences, University of Macau, Macau, China.
Research Interests: novel therapeutic antibodies development, venom-based peptide & natural biomolecule prototype drugs development, cancer biomarkers & immunotherapy markers discovery for prognostic and therapeutic validation.
Saverio Marchi
Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona, Italy.
Research Interests: cell signaling, cancer biology, cell death, molecular cell biology, mitochondria, calcium.
Enrico Mini
Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Florence, Italy.
Research Interests: leukemia, antimetabolites and metal-based drug resistance, gastrointestinal cancers, cancer pharmacogenomics, pharmacogenetics.
Gianpaolo Papaccio
Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
Research Interests: cancer stem cells, peritumoral tissue, mitochondrial transfer, organoids, adipose stem cells and cancer, hyaluronans and cancer.
Roger M. Phillips
Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield, UK.
Research Interests: tumour hypoxia, cancer metabolism, hypoxia activated prodrugs, drug discovery (including phenotypic drug evaluation), drug delivery to the tumour microenvironment.
Raphael E. Pollock
Department of Surgery, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Research Interests: sarcoma, neoplasms, neurilemmoma, gastrointestinal stromal tumors, breast neoplasms, leiomyosarcoma, neoplasm metastasis, ewing, liposarcoma, myxoid, liposarcoma.
Paolo Ettore Porporato
Department of Molecular Biotechnology and Health Science, Molecular Biotechnology Center, University of Turin, Turin, Italy.
Research Interests: cancer metabolism, muscle atrophy, mitochondrial ROS, cachexia, iron.
Jiangjiang Qin
Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
Research Interests: gastric cancer, pancreatic cancer, new target discovery, molecular mechanism of new targets, innovative drugs.
Robert W. Robey
Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Research Interests: cancer drug resistance, ATP-binding cassette transporters, ABCG2, histone deacetylase inhibitors, METTL7A.
The multidrug resistance transporter P-glycoprotein confers resistance to ferroptosis inducers
Ahmad R Safa
Department of Pharmacology & Toxicology, Indiana University School of Medicine, Indianapolis, IN, USA.
Research Interests: cancer drug resistance, cancer stem cells, apoptosis resistance, anti-apoptotic roteins, pro-apoptotic proteins.
John D. Schuetz
Department of Pharmacy and Pharmaceutical Science, St. Jude Children's Research Hospital, Memphis, TN, USA.
Research Interests: role of ABC transporters in response to chemotherapy, biological function of ABC transporters, regulation of ABC transporters.
Gautam Sethi
Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Kent Ridge, Singapore.
Research Interests: cancer, cellular and molecular mechanisms, diagnostics and therapeutics, gastrointestinal cancer.
John Seymour
Peter MacCallum Cancer Centre, Royal Melbourne Hospital & University of Melbourne, Victoria, Australia.
Research Interests: haematology, aggressive lymphoma, acute leukemia, myelodysplasia.
Rakesh Srivastava
Stanley S. Scott Cancer Center, School of Medicine, Louisiana State University Health-New Orleans, New Orleans, LA, USA.
Research Interests: apoptosis, cell signaling and human diseases, molecular mechanisms, stem cells and human diseases, nutrition, diet and cancer.
Chunxia Su
Department of Oncology, Shanghai Pulmonary Hospital and Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, China.
Research Interests: non-small cell lung cancer, lung cancer, tumor microenvironment, immunotherapy.
Dean G Tang
Professor & Chairman, Department of Pharmacology & Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Research Interests: cancer stem cells, prostate cancer, stem cells, cancer cell heterogeneity, lineage plasticity, therapy resistance, cancer vaccine.
Kenneth Kin Wah To
School of Pharmacy, the Chinese University of Hong Kong, Hong Kong, China.
Research Interests: multidrug resistance in cancer chemotherapy, drug repurposing, cancer epigenetics.
Robert C.A.M. van Waardenburg
Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, AL, USA.
Research Interests: DNA repair proteins, cellular response to chemotherapy, protein-protein interactions, post-translational modification by ubiquitin and SUMO, sulfotransferases.
Erik A. C. Wiemer
Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
Research Interests: cancer biology, biomarkers, non-coding RNAs, soft tissue sarcomas, lung cancer, ovarian cancer.
Dong-Hua Yang
New York College of Traditional Chinese Medicine, Mineola, NY, USA.
Research Interests: biomarker, pharmacology, multi-drug resistance, cancer biology, Chinese medicine, immunohistochemistry.
Xiaohe Yang
Biological and Biomedical Sciences, Julius L. Chambers Biomedical/Biotechnology Research Institute, North Carolina Central University, Durham, USA.
Research Interests: Cancer stem cells, apoptosis, receptor tyrosine kinase, cell cycle, therapeutic resistance, carcinogenesis, DNA damage, cell signaling.
All members of the Editorial Board have identified their affiliated institutions or organizations, along with the corresponding country or geographic region. OAE Publishing Inc. remains neutral with regard to any jurisdictional claims.
